Muscle function in Turner syndrome: normal force but decreased power
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11320%2F15%3A10294546" target="_blank" >RIV/00216208:11320/15:10294546 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11130/15:10294546 RIV/00064203:_____/15:10294546
Výsledek na webu
<a href="http://dx.doi.org/10.1111/cen.12518" target="_blank" >http://dx.doi.org/10.1111/cen.12518</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/cen.12518" target="_blank" >10.1111/cen.12518</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Muscle function in Turner syndrome: normal force but decreased power
Popis výsledku v původním jazyce
ObjectiveAlthough hypogonadism and SHOX gene haploinsufficiency likely cause the decreased bone mineral density and increased fracture rate associated with Turner syndrome (TS), the exact mechanism remains unclear. We tested the hypothesis that muscle dysfunction in patients with TS contributes to increased fracture risk. The secondary aim was to determine whether menarche, hormone therapy duration, positive fracture history and genotype influence muscle function parameters in patients with TS. DesignAcross-sectional study was conducted in a single university hospital referral centre between March 2012 and October 2013. PatientsSixty patients with TS (mean age of 13745years) were compared to the control group of 432 healthy girls. MeasurementsA Leonardo Mechanograph((R)) Ground Reaction Force Platform was used to assess muscle force (F-max) by the multiple one-legged hopping test and muscle power (P-max) by the single two-legged jump test. ResultsWhile the F-max was normal (mean weigh
Název v anglickém jazyce
Muscle function in Turner syndrome: normal force but decreased power
Popis výsledku anglicky
ObjectiveAlthough hypogonadism and SHOX gene haploinsufficiency likely cause the decreased bone mineral density and increased fracture rate associated with Turner syndrome (TS), the exact mechanism remains unclear. We tested the hypothesis that muscle dysfunction in patients with TS contributes to increased fracture risk. The secondary aim was to determine whether menarche, hormone therapy duration, positive fracture history and genotype influence muscle function parameters in patients with TS. DesignAcross-sectional study was conducted in a single university hospital referral centre between March 2012 and October 2013. PatientsSixty patients with TS (mean age of 13745years) were compared to the control group of 432 healthy girls. MeasurementsA Leonardo Mechanograph((R)) Ground Reaction Force Platform was used to assess muscle force (F-max) by the multiple one-legged hopping test and muscle power (P-max) by the single two-legged jump test. ResultsWhile the F-max was normal (mean weigh
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FG - Pediatrie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2015
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Clinical Endocrinology
ISSN
0300-0664
e-ISSN
—
Svazek periodika
82
Číslo periodika v rámci svazku
2
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
6
Strana od-do
248-253
Kód UT WoS článku
000348575000013
EID výsledku v databázi Scopus
2-s2.0-84921591641